HMC and Boehringer Ingelheim Partner to Boost Healthcare Innovation in Qatar
Doha: Hamad Medical Corporation (HMC) has signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, a leading biopharmaceutical company, to collaborate on initiatives aimed at strengthening clinical research, advancing healthcare innovatio…